- Home
- NIXX vs NRSN Comparison
NIXX vs NRSN Comparison
Compare NIXX & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIXX
- NRSN
- Stock Information
- Founded
- NIXX 2010
- NRSN 2017
- Country
- NIXX United States
- NRSN Israel
- Employees
- NIXX N/A
- NRSN N/A
- Industry
- NIXX
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- NIXX
- NRSN Health Care
- Exchange
- NIXX NYSE
- NRSN Nasdaq
- Market Cap
- NIXX 28.7M
- NRSN 26.0M
- IPO Year
- NIXX N/A
- NRSN 2021
- Fundamental
- Price
- NIXX $1.56
- NRSN $0.99
- Analyst Decision
- NIXX
- NRSN Hold
- Analyst Count
- NIXX 0
- NRSN 1
- Target Price
- NIXX N/A
- NRSN N/A
- AVG Volume (30 Days)
- NIXX 239.6K
- NRSN 130.1K
- Earning Date
- NIXX 05-14-2025
- NRSN 04-07-2025
- Dividend Yield
- NIXX N/A
- NRSN N/A
- EPS Growth
- NIXX N/A
- NRSN N/A
- EPS
- NIXX N/A
- NRSN N/A
- Revenue
- NIXX $612,046.00
- NRSN N/A
- Revenue This Year
- NIXX N/A
- NRSN N/A
- Revenue Next Year
- NIXX N/A
- NRSN N/A
- P/E Ratio
- NIXX N/A
- NRSN N/A
- Revenue Growth
- NIXX N/A
- NRSN N/A
- 52 Week Low
- NIXX $1.26
- NRSN $0.51
- 52 Week High
- NIXX $8.50
- NRSN $1.50
- Technical
- Relative Strength Index (RSI)
- NIXX N/A
- NRSN 44.13
- Support Level
- NIXX N/A
- NRSN $0.97
- Resistance Level
- NIXX N/A
- NRSN $1.04
- Average True Range (ATR)
- NIXX 0.00
- NRSN 0.09
- MACD
- NIXX 0.00
- NRSN 0.00
- Stochastic Oscillator
- NIXX 0.00
- NRSN 57.04
About NIXX NIXXY INC
Nixxy Inc formerly Recruiter.Com Group Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology. The Recruiter.com network of over 28,000 small and independent recruiters utilize a web platform, complete with AI-driven job matching, to recruit talent faster. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.